Infinium Global Research Biological Drugs Market | Page 3

autoimmune diseases, and other chronic illnesses with minimal side effects when compared to chemical drugs is expected to
provide opportunities for major players in the biological drugs market during the forecast period.
Segments Covered:
The report segments the global biological drugs market by product and region. On the basis of product, the market is
segmented as protein therapy, mAb therapy and vaccines. Monoclonal antibodies segment is expected to sustain a major
share in the global biological drugs market during the forecast period. Among protein therapy segment, Enbrel is expected to
attain more demand with fastest growth rate during the forecast period. Among the vaccines, the demand for Prevnar 13 is
anticipated to grow significantly during the forecast period.
Geographic Coverage and Analysis:
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the
World. North America dominates the global biological drugs market with a major share. Increasing technological
advancements, favorable regulatory policies and increasing awareness about the biological due to intervention of
governments and other agencies are the major factors that drive the growth of the North American biological drugs market.
Moreover, the increasing demand for biological drugs for the treatment of chronic illnesses such as cancer and diabetes is
anticipated to drive the growth of the North American biological market during the forecast period. The presence of large
geriatric population in the countries such as Germany and United Kingdom drive the growth of European biological drugs
market. Furthermore, presence of top quality research and development infrastructure due to the partnerships between
research institutes and manufacturing companies and increased funding from private-public initiatives drives the growth of
th